Aukstikalne, L., Klejus, I., Thastrup, M., Zvirblis, T., Schmiegelow, K., Vaitkeviciene, G. E., & Toksvang, L. N. (2023, December). Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemia. EJC Paediatric Oncology.
Chicago Style (17th ed.) CitationAukstikalne, Lauryna, Ignas Klejus, Maria Thastrup, Tadas Zvirblis, Kjeld Schmiegelow, Goda Elizabeta Vaitkeviciene, and Linea Natalie Toksvang. "Erythrocyte-incorporated 6-mercaptopurine Metabolite Levels Are Not Affected by Recent Drug Administration During Maintenance Therapy for Childhood Acute Lymphoblastic Leukemia." EJC Paediatric Oncology Dec. 2023.
MLA (9th ed.) CitationAukstikalne, Lauryna, et al. "Erythrocyte-incorporated 6-mercaptopurine Metabolite Levels Are Not Affected by Recent Drug Administration During Maintenance Therapy for Childhood Acute Lymphoblastic Leukemia." EJC Paediatric Oncology, Dec. 2023.
